{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:58:32Z","timestamp":1792112312791,"version":"4.4.0"},"reference-count":116,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Child and Adolescent Psychiatric Clinics of North America"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.chc.2010.03.010","type":"journal-article","created":{"date-parts":[[2010,6,9]],"date-time":"2010-06-09T04:50:26Z","timestamp":1276059026000},"page":"591-608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Pharmacotherapies for Adolescent Substance Use Disorders"],"prefix":"10.1016","volume":"19","author":[{"given":"Deborah R.","family":"Simkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severin","family":"Grenoble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chc.2010.03.010_bib1","unstructured":"Baird A, Fugelsang J, Bennett C. What you were thinking: an fMRI study of adolescent decision-making. Poster Presentation at the Cognitive Neuroscience Conference. New York, April, 2005."},{"issue":"1","key":"10.1016\/j.chc.2010.03.010_bib2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.dr.2007.08.003","article-title":"The adolescent brain","volume":"28","author":"Casey","year":"2008","journal-title":"Dev Rev"},{"key":"10.1016\/j.chc.2010.03.010_bib3","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1196\/annals.1308.035","article-title":"The emergence of collaborative brain function: FMRI studies of the development of response inhibition","volume":"1021","author":"Luna","year":"2004","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.chc.2010.03.010_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jsat.2003.09.005","article-title":"The cannabis youth treatment (CYT) study: main findings from two randomized trials","volume":"27","author":"Dennis","year":"2004","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"1","key":"10.1016\/j.chc.2010.03.010_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004583-199301000-00001","article-title":"Antidepressant treatments in children and adolescents. I. Affective disorders","volume":"32","author":"Ambrosini","year":"1993","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"10.1016\/j.chc.2010.03.010_bib6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00004583-199305000-00001","article-title":"Antidepressant treatments in children and adolescents: II. Anxiety, physical, and behavioral disorders","volume":"32","author":"Ambrosini","year":"1993","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.chc.2010.03.010_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.15288\/jsas.1999.s13.22","article-title":"The development of alcohol and other substance use: a gender study of family and peer context","volume":"13","author":"Hops","year":"1999","journal-title":"J\u00a0Stud Alcohol Suppl"},{"key":"10.1016\/j.chc.2010.03.010_bib8","first-page":"3470","article-title":"Adolescent substance abuse","volume":"vol. 2","author":"Simkin","year":"2004"},{"issue":"6","key":"10.1016\/j.chc.2010.03.010_bib9","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/00004583-200206000-00007","article-title":"Attention dysfunction predicts substance involvement in community youths","volume":"41","author":"Tapert","year":"2002","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.chc.2010.03.010_bib10","series-title":"Clinical manual of adolescent substance abuse treatment","first-page":"205","article-title":"Pharmacotherapy of adolescent substance use disorders","author":"Kaminer","year":"2010"},{"issue":"5","key":"10.1016\/j.chc.2010.03.010_bib11","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1089\/cap.2005.15.810","article-title":"Pharmacotherapy of adolescent substance use disorders: a review of the literature","volume":"15","author":"Waxmonsky","year":"2005","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.chc.2010.03.010_bib12","first-page":"291","article-title":"Pharmacotherapy for adolescents with psychoactive substance abuse disorders","volume":"156","author":"Kaminer","year":"1995","journal-title":"NIDA Res Monogr"},{"issue":"5","key":"10.1016\/j.chc.2010.03.010_bib13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.15288\/jsa.1998.59.581","article-title":"The clinical course of alcohol-related problems in alcohol dependent and nonalcohol dependent drinking women and men","volume":"59","author":"Schuckit","year":"1998","journal-title":"J\u00a0Stud Alcohol"},{"issue":"5","key":"10.1016\/j.chc.2010.03.010_bib14","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1176\/appi.ajp.157.5.745","article-title":"Age at first alcohol use: a risk factor for the development of alcohol disorders","volume":"157","author":"DeWit","year":"2000","journal-title":"Am J Psychiatry"},{"issue":"7","key":"10.1016\/j.chc.2010.03.010_bib15","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/j.1360-0443.2008.02223.x","article-title":"Impulsivity, age of first alcohol use and substance use disorders among male adolescents: a population based case-control study","volume":"103","author":"von Diemen","year":"2008","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.chc.2010.03.010_bib16","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1176\/ajp.147.11.1537","article-title":"The natural history of alcohol abuse: implications for definitions of alcohol use disorders","volume":"147","author":"Hasin","year":"1990","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.chc.2010.03.010_bib17","series-title":"Adolescent substance abuse: psychiatric comorbidity and high-risk behaviors","first-page":"145","article-title":"Pharmacological interventions for adolescent substance use disorders","author":"Upahdyaya","year":"2008"},{"issue":"2","key":"10.1016\/j.chc.2010.03.010_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0740-5472(90)90002-8","article-title":"Long-term abstinence from alcohol in patients receiving aversion therapy as part of a multimodal inpatient program","volume":"7","author":"Smith","year":"1990","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"5","key":"10.1016\/j.chc.2010.03.010_bib19","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1530-0277.1991.tb00614.x","article-title":"Six- and twelve-month abstinence rates in inpatient alcoholics treated with aversion therapy compared with matched inpatients from a treatment registry","volume":"15","author":"Smith","year":"1991","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"10.1016\/j.chc.2010.03.010_bib20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0740-5472(93)90021-S","article-title":"Treatment outcome of 600 chemically dependent patients treated in a multimodal inpatient program including aversion therapy and pentothal interviews","volume":"10","author":"Smith","year":"1993","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"1","key":"10.1016\/j.chc.2010.03.010_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1300\/J069v16n01_02","article-title":"Six- and twelve-month abstinence rates in inpatient alcoholics treated with either faradic aversion or chemical aversion compared with matched inpatients from a treatment registry","volume":"16","author":"Smith","year":"1997","journal-title":"J\u00a0Addict Dis"},{"issue":"1","key":"10.1016\/j.chc.2010.03.010_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0740-5472(90)90033-M","article-title":"Chemical aversion therapy in the treatment of cocaine dependence as part of a multimodal treatment program: treatment outcome","volume":"7","author":"Frawley","year":"1990","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"4","key":"10.1016\/j.chc.2010.03.010_bib23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0740-5472(92)90020-O","article-title":"One-year follow-up after multimodal inpatient treatment for cocaine and methamphetamine dependencies","volume":"9","author":"Frawley","year":"1992","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"11","key":"10.1016\/j.chc.2010.03.010_bib24","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/jama.1986.03380110055026","article-title":"Disulfiram treatment of alcoholism. A Veterans Administration cooperative study","volume":"256","author":"Fuller","year":"1986","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.chc.2010.03.010_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/0959523031000154436","article-title":"Comparison of disulfiram and placebo in treatment of alcohol dependence of adolescents","volume":"22","author":"Niederhofer","year":"2003","journal-title":"Drug Alcohol Rev"},{"issue":"4","key":"10.1016\/j.chc.2010.03.010_bib26","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/00004583-199405000-00006","article-title":"Disulfiram for alcohol use disorders in adolescents","volume":"33","author":"Myers","year":"1994","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"8","key":"10.1016\/j.chc.2010.03.010_bib27","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1176\/appi.ajp.162.8.1403","article-title":"The neural basis of addiction: a pathology of motivation and choice","volume":"162","author":"Kalivas","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.chc.2010.03.010_bib28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1360-0443.2006.01586.x","article-title":"The neurobiology of addiction: a neuroadaptational view relevant for diagnosis","volume":"101","author":"Koob","year":"2006","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.chc.2010.03.010_bib29","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/nn1578","article-title":"Is there a common molecular pathway for addiction?","volume":"8","author":"Nestler","year":"2005","journal-title":"Nat Neurosci"},{"issue":"3","key":"10.1016\/j.chc.2010.03.010_bib30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/105504901750532094","article-title":"Molecular neurobiology of addiction","volume":"10","author":"Nestler","year":"2001","journal-title":"Am J Addict"},{"issue":"3","key":"10.1016\/j.chc.2010.03.010_bib31","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00787-003-0327-1","article-title":"Acamprosate and its efficacy in treating alcohol dependent adolescents","volume":"12","author":"Niederhofer","year":"2003","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"8","key":"10.1016\/j.chc.2010.03.010_bib32","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1097\/01.alc.0000174913.60384.e8","article-title":"Role of the endogenous opioid system on the neuropsychopharmacological effects of ethanol: new insights about an old question","volume":"29","author":"Sanchis-Segura","year":"2005","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"10.1016\/j.chc.2010.03.010_bib33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/1874473710801020239","article-title":"Role of mu and delta opioid receptors in alcohol drinking behaviour","volume":"1","author":"Mendez","year":"2008","journal-title":"Curr Drug Abuse Rev"},{"issue":"5","key":"10.1016\/j.chc.2010.03.010_bib34","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1089\/cap.2005.15.723","article-title":"Naltrexone treatment of adolescent alcoholics: an open-label pilot study","volume":"15","author":"Deas","year":"2005","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"1","key":"10.1016\/j.chc.2010.03.010_bib35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00004583-199701000-00010","article-title":"Naltrexone for alcohol abuse","volume":"36","author":"Wold","year":"1997","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"10.1016\/j.chc.2010.03.010_bib36","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1176\/ajp.154.3.439b","article-title":"Naltrexone for alcoholic adolescents","volume":"154","author":"Lifrak","year":"1997","journal-title":"Am J Psychiatry"},{"issue":"8","key":"10.1016\/j.chc.2010.03.010_bib37","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jama.284.8.963","article-title":"Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: a randomized controlled trial","volume":"284","author":"Johnson","year":"2000","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.chc.2010.03.010_bib38","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00213-002-1002-9","article-title":"Ondansetron reduces the craving of biologically predisposed alcoholics","volume":"160","author":"Johnson","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"issue":"11","key":"10.1016\/j.chc.2010.03.010_bib39","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1097\/01.ALC.0000095635.46911.5D","article-title":"Ondansetron reduces mood disturbance among biologically predisposed, alcohol-dependent individuals","volume":"27","author":"Johnson","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"issue":"7","key":"10.1016\/j.chc.2010.03.010_bib40","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/01.ALC.0000075547.77464.76","article-title":"Effects of ondansetron in early-versus late-onset alcoholics: a prospective, open-label study","volume":"27","author":"Kranzler","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"10.1016\/j.chc.2010.03.010_bib41","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1530-0277.1994.tb00054.x","article-title":"Clinical efficacy of the 5-HT3 antagonist ondansetron in alcohol abuse and dependence","volume":"18","author":"Sellers","year":"1994","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"10.1016\/j.chc.2010.03.010_bib42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0091-3057(99)00184-7","article-title":"Delta-opioid and 5-HT3 receptor antagonist effects on ethanol reward and discrimination in C57BL\/6 mice","volume":"65","author":"Middaugh","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"10.1016\/j.chc.2010.03.010_bib43","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.addbeh.2004.10.011","article-title":"A\u00a0prospective, open-label trial of ondansetron in adolescents with alcohol dependence","volume":"30","author":"Dawes","year":"2005","journal-title":"Addict Behav"},{"issue":"9","key":"10.1016\/j.chc.2010.03.010_bib44","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.addbeh.2005.07.004","article-title":"Reductions in and relations between \u201ccraving\u201d and drinking in a prospective, open-label trial of ondansetron in adolescents with alcohol dependence","volume":"30","author":"Dawes","year":"2005","journal-title":"Addict Behav"},{"issue":"9370","key":"10.1016\/j.chc.2010.03.010_bib45","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(03)13370-3","article-title":"Oral topiramate for treatment of alcohol dependence: a randomised controlled trial","volume":"361","author":"Johnson","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.chc.2010.03.010_bib46","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2174\/1874473710902020135","article-title":"Review of topiramate: an antiepileptic for the treatment of alcohol dependence","volume":"2","author":"Kenna","year":"2009","journal-title":"Curr Drug Abuse Rev"},{"issue":"5","key":"10.1016\/j.chc.2010.03.010_bib47","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/alcalc\/37.5.504","article-title":"Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study","volume":"37","author":"Addolorato","year":"2002","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.chc.2010.03.010_bib48","series-title":"The psychiatric clinics of North America annual of drug therapy","first-page":"211","article-title":"Pharmacotherapy of substance abuse and dependence","author":"Gastfriend","year":"1998"},{"issue":"4","key":"10.1016\/j.chc.2010.03.010_bib49","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/clpt.1990.62","article-title":"Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers","volume":"47","author":"Naranjo","year":"1990","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.chc.2010.03.010_bib50","first-page":"153","article-title":"Endocannabinoid system: an overview of its potential in current medical practice","volume":"30","author":"Mouslech","year":"2009","journal-title":"Neuro Endocrinol Lett"},{"issue":"1","key":"10.1016\/j.chc.2010.03.010_bib51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/alcalc\/agh111","article-title":"Role of the endocannabinoid system in the development of tolerance to alcohol","volume":"40","author":"Basavarajappa","year":"2005","journal-title":"Alcohol Alcohol"},{"issue":"3","key":"10.1016\/j.chc.2010.03.010_bib52","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1358\/dnp.2008.21.3.1203411","article-title":"The role of the endogenous cannabinoid system in drug addiction","volume":"21","author":"Parolaro","year":"2008","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.chc.2010.03.010_bib53","first-page":"181","article-title":"Divalproex sodium for use with conduct disordered adolescent marijuana users: letter to the editor","volume":"5","author":"Donovan","year":"1996","journal-title":"Am J Addict"},{"issue":"1","key":"10.1016\/j.chc.2010.03.010_bib54","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4088\/JCP.v58n0102","article-title":"Divalproex treatment of disruptive adolescents: a report of 10 cases","volume":"58","author":"Donovan","year":"1997","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.chc.2010.03.010_bib55","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1586\/14737175.8.3.479","article-title":"Pharmacotherapy and psychotherapy in cannabis withdrawal and dependence","volume":"8","author":"Benyamina","year":"2008","journal-title":"Expert Rev Neurother"},{"issue":"4","key":"10.1016\/j.chc.2010.03.010_bib56","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/archpsyc.58.4.322","article-title":"Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716","volume":"58","author":"Huestis","year":"2001","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"10.1016\/j.chc.2010.03.010_bib57","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00213-007-0861-5","article-title":"Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users","volume":"194","author":"Huestis","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.chc.2010.03.010_bib58","first-page":"321","article-title":"COMT- Inhibitors may be a promising tool in treatment of marijuana addiction","volume":"18","author":"Shafa","year":"2009","journal-title":"Am J Addict"},{"issue":"3","key":"10.1016\/j.chc.2010.03.010_bib59","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.drugalcdep.2006.02.011","article-title":"A\u00a0preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of cocaine dependence","volume":"84","author":"Johnson","year":"2006","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.chc.2010.03.010_bib60","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.pnpbp.2006.10.001","article-title":"An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study","volume":"31","author":"Mardikian","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.chc.2010.03.010_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006754.pub2","article-title":"Anticonvulsants for cocaine dependence","volume":"16","author":"Minozzi","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.chc.2010.03.010_bib62","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/02791072.2001.10400575","article-title":"Divalproex loading in the treatment of cocaine dependence","volume":"33","author":"Myrick","year":"2001","journal-title":"J\u00a0Psychoactive Drugs"},{"key":"10.1016\/j.chc.2010.03.010_bib63","article-title":"Antidepressants for cocaine dependence","volume":"3","author":"Silva de Lima","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.chc.2010.03.010_bib64","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.addbeh.2007.11.011","article-title":"A\u00a0double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence","volume":"33","author":"Pettinati","year":"2008","journal-title":"Addict Behav"},{"issue":"2","key":"10.1016\/j.chc.2010.03.010_bib65","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0306-4603(00)00098-8","article-title":"Naltrexone and relapse prevention treatment for cocaine-dependent patients","volume":"26","author":"Schmitz","year":"2001","journal-title":"Addict Behav"},{"issue":"4","key":"10.1016\/j.chc.2010.03.010_bib66","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/archpsyc.1989.01810040028005","article-title":"Outpatient treatment of \u2018crack\u2019 cocaine smoking with flupenthixol decanoate. A preliminary report","volume":"46","author":"Gawin","year":"1989","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1016\/j.chc.2010.03.010_bib67","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0376-8716(03)00009-7","article-title":"A\u00a0pilot trial of olanzapine for the treatment of cocaine dependence","volume":"70","author":"Kampman","year":"2003","journal-title":"Drug Alcohol Depend"},{"issue":"Suppl 1","key":"10.1016\/j.chc.2010.03.010_bib68","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1360-0443.2005.00990.x","article-title":"A\u00a0placebo-controlled screening trial of olanzapine, valproate, and coenzyme Q10\/L-carnitine for the treatment of cocaine dependence","volume":"100","author":"Reid","year":"2005","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.chc.2010.03.010_bib69","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1586\/14760584.1.3.365","article-title":"Therapeutic vaccines for substance dependence","volume":"1","author":"Kosten","year":"2002","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"10.1016\/j.chc.2010.03.010_bib70","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.biopsych.2005.04.032","article-title":"Vaccine pharmacotherapy for the treatment of cocaine dependence","volume":"58","author":"Martell","year":"2005","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.chc.2010.03.010_bib71","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00004583-199203000-00020","article-title":"Desipramine facilitation of cocaine abstinence in an adolescent","volume":"31","author":"Kaminer","year":"1992","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"10.1016\/j.chc.2010.03.010_bib72","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/00004583-199405000-00022","article-title":"Cocaine craving","volume":"33","author":"Kaminer","year":"1994","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"11","key":"10.1016\/j.chc.2010.03.010_bib73","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/archgenpsychiatry.2009.142","article-title":"A\u00a0randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies","volume":"66","author":"Piper","year":"2009","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"10.1016\/j.chc.2010.03.010_bib74","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1360-0443.2009.02548.x","article-title":"Extended treatment of older cigarette smokers","volume":"104","author":"Hall","year":"2009","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.chc.2010.03.010_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003289.pub4","article-title":"Tobacco cessation interventions for young people","volume":"18","author":"Grimshaw","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.chc.2010.03.010_bib76","article-title":"Tobacco cessation interventions for young people","volume":"1","author":"Grimson","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"1\u20132","key":"10.1016\/j.chc.2010.03.010_bib77","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.drugalcdep.2007.12.002","article-title":"Cigarette reduction: an intervention for adolescent smokers","volume":"95","author":"Hanson","year":"2008","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.chc.2010.03.010_bib78","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1300\/J069v25n02_07","article-title":"Antidepressant treatment patterns in a novel methadone maintenance clinic targeting young adults an observational study","volume":"25","author":"Galarneau","year":"2006","journal-title":"J\u00a0Addict Dis"},{"issue":"11","key":"10.1016\/j.chc.2010.03.010_bib79","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1001\/archpsyc.1992.01820110064010","article-title":"New pharmacotherapies for cocaine dependence. revisited","volume":"49","author":"Meyer","year":"1992","journal-title":"Arch Gen Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.chc.2010.03.010_bib80","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.drugalcdep.2006.10.011","article-title":"Safety, tolerability and efficacy of levodopa-carbidopa treatment for cocaine dependence: two double-blind, randomized, clinical trials","volume":"88","author":"Mooney","year":"2007","journal-title":"Drug Alcohol Depend"},{"issue":"1\u20133","key":"10.1016\/j.chc.2010.03.010_bib81","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.drugalcdep.2007.11.004","article-title":"Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform","volume":"94","author":"Schmitz","year":"2008","journal-title":"Drug Alcohol Depend"},{"issue":"Suppl 1","key":"10.1016\/j.chc.2010.03.010_bib82","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1360-0443.2005.00991.x","article-title":"Randomized controlled pilot trial of cabergoline, hydergine and levodopa\/carbidopa: Los Angeles Cocaine Rapid Efficacy Screening Trial (CREST)","volume":"100","author":"Shoptaw","year":"2005","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.chc.2010.03.010_bib83","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/npp.1993.42","article-title":"A\u00a0placebo-controlled trial of L-dopa\/carbidopa in early cocaine abstinence","volume":"9","author":"Wolfsohn","year":"1993","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.chc.2010.03.010_bib84","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4088\/JCP.v59n0605","article-title":"Methylphenidate treatment for cocaine abusers with adult attention-deficit\/hyperactivity disorder: a pilot study","volume":"59","author":"Levin","year":"1998","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.chc.2010.03.010_bib85","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.drugalcdep.2006.07.004","article-title":"Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo","volume":"87","author":"Levin","year":"2007","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"10.1016\/j.chc.2010.03.010_bib86","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00004714-200110000-00010","article-title":"Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial","volume":"21","author":"Grabowski","year":"2001","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"5","key":"10.1016\/j.chc.2010.03.010_bib87","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/sj.npp.1300392","article-title":"Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials","volume":"29","author":"Grabowski","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.chc.2010.03.010_bib88","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1046\/j.1360-0443.2003.00447.x","article-title":"Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence","volume":"98","author":"Shearer","year":"2003","journal-title":"Addiction"},{"issue":"1\u20132","key":"10.1016\/j.chc.2010.03.010_bib89","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugalcdep.2008.10.016","article-title":"Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial","volume":"101","author":"Mooney","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"10.1016\/j.chc.2010.03.010_bib90","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/00004583-200010000-00021","article-title":"Heroin use among adolescents in treatment for substance use disorders","volume":"39","author":"Hopfer","year":"2000","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.chc.2010.03.010_bib91","series-title":"The treatment of opioid dependence","first-page":"497","article-title":"Treatment of adolescents","author":"Marsch","year":"2005"},{"key":"10.1016\/j.chc.2010.03.010_bib92","series-title":"Substance abuse comprehensive textbook","first-page":"628","article-title":"Maternal and neonatal effects of alcohol and drugs","author":"Finnegan","year":"1992"},{"issue":"17","key":"10.1016\/j.chc.2010.03.010_bib93","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.2008.567","article-title":"Treatment of adolescent opioid dependence: no quick fix","volume":"300","author":"Fiellin","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.chc.2010.03.010_bib94","first-page":"82","article-title":"The use of 1-alpha-acetyl-methadol (LAAM) as compared to methadone in the maintenance and detoxification of young heroin addicts. 1973 [proceedings]","volume":"8","author":"Lehmann","year":"1976","journal-title":"NIDA Res Monogr"},{"issue":"17","key":"10.1016\/j.chc.2010.03.010_bib95","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2008.574","article-title":"Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial","volume":"300","author":"Woody","year":"2008","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.chc.2010.03.010_bib96","article-title":"Maintenance treatments for opiate dependent adolescent","volume":"15","author":"Minozzi","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.chc.2010.03.010_bib97","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3109\/00952997409040870","article-title":"Naloxone in the treatment of the young heroin abuser","volume":"1","author":"Pierson","year":"1974","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"2","key":"10.1016\/j.chc.2010.03.010_bib98","first-page":"195","article-title":"Tip of the national iceberg? Profile of adolescent patients prescribed methadone in an innovative community drug service","volume":"5","author":"Crome","year":"1998","journal-title":"Drugs: Education, Prevention, Policy"},{"issue":"1","key":"10.1016\/j.chc.2010.03.010_bib99","first-page":"87","article-title":"The development of a unique designated community drug service for adolescents: policy, prevention and education implications","volume":"7","author":"Crome","year":"2000","journal-title":"Drugs: Education, Prevention, Policy"},{"issue":"5","key":"10.1016\/j.chc.2010.03.010_bib100","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3109\/10826087309071075","article-title":"Adolescents and short term, low dose methadone maintenance","volume":"8","author":"DeAngelis","year":"1973","journal-title":"Int J Addict"},{"issue":"2","key":"10.1016\/j.chc.2010.03.010_bib101","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/10826087409057344","article-title":"Evolution of a treatment approach for young heroin addicts. Comparison of three treatment modalities","volume":"9","author":"Lloyd","year":"1974","journal-title":"Int J Addict"},{"key":"10.1016\/j.chc.2010.03.010_bib102","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1749-6632.1978.tb16772.x","article-title":"Therapeutic detoxification of adolescent heroin addicts","volume":"311","author":"Millman","year":"1978","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"10.1016\/j.chc.2010.03.010_bib103","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/jama.1972.03200070079014","article-title":"Methadone use in adolescent heroin addicts","volume":"220","author":"Rosenberg","year":"1972","journal-title":"JAMA"},{"key":"10.1016\/j.chc.2010.03.010_bib104","series-title":"Youth drug abuse: problems, issues and treatment","first-page":"571","article-title":"Evaluation of treatment outcome for youths in the drug abuse reporting program (DARP): a follow-up study","author":"Sells","year":"1979"},{"issue":"3","key":"10.1016\/j.chc.2010.03.010_bib105","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0740-5472(02)00250-7","article-title":"Adolescent heroin use: a review of the descriptive and treatment literature","volume":"23","author":"Hopfer","year":"2002","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"2","key":"10.1016\/j.chc.2010.03.010_bib106","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/09595230500537670","article-title":"Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: a file review","volume":"25","author":"Bell","year":"2006","journal-title":"Drug Alcohol Rev"},{"issue":"3","key":"10.1016\/j.chc.2010.03.010_bib107","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1300\/J069v25n03_03","article-title":"Adolescent and young adult heroin patients: drug use and success in methadone maintenance treatment","volume":"25","author":"Kellogg","year":"2006","journal-title":"J\u00a0Addict Dis"},{"key":"10.1016\/j.chc.2010.03.010_bib108","article-title":"Detoxification treatments for opiate dependent adolescents","volume":"2","author":"Minozzi","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"10.1016\/j.chc.2010.03.010_bib109","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1055\/s-2004-828448","volume":"31","author":"Ebner","year":"2004","journal-title":"Psychiatr Prax"},{"issue":"4","key":"10.1016\/j.chc.2010.03.010_bib110","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1360-0443.2003.00334.x","article-title":"Short-term outcomes after brief ambulatory opioid detoxification with buprenorphine in young heroin users","volume":"98","author":"Gandhi","year":"2003","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.chc.2010.03.010_bib111","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1360-0443.2006.01731.x","article-title":"Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment","volume":"102","author":"Nielsen","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.chc.2010.03.010_bib112","series-title":"Adolescent substance abuse: a comprehensive guide to theory and practice","author":"Kaminer","year":"1994"},{"issue":"7","key":"10.1016\/j.chc.2010.03.010_bib113","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/00004583-199707000-00016","article-title":"Clinical characteristics of psychiatrically referred adolescent outpatients with substance use disorder","volume":"36","author":"Wilens","year":"1997","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"10.1016\/j.chc.2010.03.010_bib114","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/01.chi.0000159135.33706.37","article-title":"Practice parameter for the assessment and treatment of children and adolescents with substance use disorders","volume":"44","author":"Bukstein","year":"2005","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"10.1016\/j.chc.2010.03.010_bib115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00004583-199701000-00016","article-title":"Case study: adverse effects of smoking marijuana while receiving tricyclic antidepressants","volume":"36","author":"Wilens","year":"1997","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.chc.2010.03.010_bib116","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/08897070903442665","article-title":"Psychotropic medications and substances of abuse interactions in youth","volume":"31","author":"Kaminer","year":"2010","journal-title":"Subst Abuse"}],"container-title":["Child and Adolescent Psychiatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105649931000026X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105649931000026X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T22:40:10Z","timestamp":1761000010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105649931000026X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":116,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S105649931000026X"],"URL":"https:\/\/doi.org\/10.1016\/j.chc.2010.03.010","relation":{},"ISSN":["1056-4993"],"issn-type":[{"value":"1056-4993","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacotherapies for Adolescent Substance Use Disorders","name":"articletitle","label":"Article Title"},{"value":"Child and Adolescent Psychiatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chc.2010.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}